In a small-scale trial of 10 patients with damaged knee joints, doctors harvested cells from their noses to engineer new cartilage tissue and transplant it into their damaged knees. In a paper published in The Lancet, the Swiss squad describes how 2 years later transplant, most of the patients had developed new tissue like to normal cartilage and reported improvements in knee function, pain, and quality of life.

Man clutching painful knee Share on Pinterest
Every year, approximately ii 1000000 people in Europe and the United States are diagnosed with damage to articulatio genus joints arising from injuries or accidents.

However, the authors signal out that while the results of their phase I study are promising and testify the approach is viable and safe, there is still a long way to become earlier such a procedure tin exist approved for routine use with patients.

They notation that the observational written report just involved a small-scale number of patients, there was no control grouping, and the follow-up was quite short.

There at present needs to be randomized trials – with longer follow-up – that compare the promising treatment with conventional alternatives.

Lead writer Ivan Martin, professor of tissue engineering at the Academy of Basel and University Hospital Basel in Switzerland, adds:

"Moreover, in social club to extend the potential employ of this technique to older people or those with degenerative cartilage pathologies like osteoarthritis, a lot more fundamental and pre-clinical research work needs to be done."

About 2 million people in Europe and the Usa are diagnosed with damage to articulatio genus joint cartilage every year, acquired by injury or blow.

Joint or articular cartilage is the layer of smooth tissue at the ends of bones that eases movement, and protects and cushions the surfaces of the articulation where the bones run into.

Every bit this tissue has no blood supply, if information technology gets damaged it cannot regenerate. Eventually, every bit the cartilage wears away, the bones become exposed and inflamed from rubbing against each other, leading to painful joint conditions like osteoarthritis.

There are medical techniques – such as microfracture surgery – that can prevent or delay the onset of cartilage degeneration following injury or accident, but they practise not regenerate healthy cartilage to protect the joints.

At that place have besides been attempts to use cartilage cells or chondrocytes from the patients' own joints to make new cartilage in the joint, but these have not been very successful at creating the right structure and function of the cushioning tissue.

One of the unique features of the new written report is that Prof. Martin and colleagues used chondrocytes harvested from a site far away from the damaged joint – from the patients' nasal septum. These cells have a unique ability to grow new cartilage tissue.

For the study, the team enrolled 10 patients (age xviii-55) with full-thickness cartilage damage to the knee and took a biopsy from their nasal septum under local anesthetic. They grew chondrocytes harvested from the biopsy tissue by stimulating them with growth factor for 2 weeks.

The team and then took the cultured new cells and seeded them onto "scaffolding" made of collagen and grew them for some other 2 weeks. The issue was a 2-millimeter thick graft of new cartilage measuring about 30-twoscore millimeters.

Each patient then underwent surgery where the damaged knee cartilage was removed and replaced with their ain cultured graft cutting into the appropriate shape.

After ii years, scans showed new tissue of similar composition to cartilage had grown at the affected sites.

Nine of the 10 patients – one was excluded because of sports injuries not related to the trial – also reported meaning improvements in the use and part of their knee and reduction in hurting, compared with pre-surgery.

The authors note in that location were no reports of adverse reactions to the surgery, although there were two reports of injuries not related to the procedure.

In an accompanying annotate article, Dr. Nicole Rotter, from Ulm University Medical Center, and Dr. Rolf Brenner, from the University of Ulm – both in Germany – say the trial "represents an important advance towards less invasive, jail cell-based repair technologies for articular cartilage defects."

The principal reason they requite is that the cells were non taken from healthy tissue near the site of injury but from a completely unaffected part of the torso, which avoids the adventure of harvesting affecting the damaged joint.

They also mention the promising result that patient age does non appear to affect the success of the procedure.

However, like the trial authors, they conclude that only longer-term randomized, controlled trials – that amidst other things examination the quality of the repair tissue – will be needed before we can say whether this arroyo is likely to proceeds regulatory blessing and reach clinical use.

"Our findings confirm the safety and feasibility of cartilage grafts engineered from nasal cells to repair damaged human knee cartilage. But use of this procedure in everyday clinical practise is however a long way off as information technology requires rigorous assessment of efficacy in larger groups of patients and the development of manufacturing strategies to ensure cost effectiveness."

Prof. Ivan Martin

Learn about 10 exercises that can assistance ease the effects of human knee arthritis.